To assess the impact of 17β-HSD12 on proliferation and migratory potential of tumor cells, we used four breast cancer cell lines, each representing one of the three main molecular subtypes of breast cancer; the MCF7 that is positive for the estrogen receptor-α (ER) and progesterone receptor (PR) but negative for the human epidermal growth factor receptor 2 (HER2), the MDA-MB-453 that is negative for ER and PR but positive for HER2, and the SUM159 and MDA-MB-231 that are triple-negative (ER−, PR−, HER2−). Here, PGR is linked to neoplasm.